Evan Levine Insider Profile
4 Followers
Evan Levine, former Chief Executive Officer at PsyBio Therapeutics, holds 5.10M shares in PsyBio Therapeutics (Ticker: TSE:PSYB.H). Most recently, Evan Levine Bought 5,098,042 shares of PsyBio Therapeutics on Jan 13, 2023 for an estimated value of C$254.90K.
Evan Levine's Trading History
| PSYB.HPsyBio Therapeutics | Jan 13, 2023 | ― | Informative Buy | 254.90K | C$50.98K | |||||||||||||||
TSE:PSYB.H
| ||||||||||||||||||||
You May Also Like
Evan Levine insider profile FAQ
What stocks does Evan Levine hold?
Evan Levine holds: TSE:PSYB.H stocks.
What was Evan Levine’s latest transaction?
Evan Levine’s latest transaction was an Informative Buy of C$254.90K.
What is Evan Levine's role in PsyBio Therapeutics?
Evan Levine's role in PsyBio Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
